Kawahara T, Shimizu I, Ohdan H, Zhao G, Sykes M
Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Am J Transplant. 2005 Dec;5(12):2821-9. doi: 10.1111/j.1600-6143.2005.01121.x.
Mixed hematopoietic chimerism induced via nonmyeloablative bone marrow transplantation (BMT) leads to unresponsiveness of anti-Gal alpha1,3Gal beta1,4G1cNAc (Gal) natural antibody (NAb)-producing cells in alpha1,3-galactosyltransferase deficient (GalT(-/-)) mice. We analyzed the mechanisms of anti-Gal-producing B cell unresponsiveness induced by Gal(+/+) BMT. C57BL/6 (B6) GalT(-/-) mice received 3Gy whole-body irradiation and BMT from B6-CD45 congenic mice. BMT led to marked reductions in serum anti-Gal IgM levels and in the numbers of splenic anti-Gal-producing cells by 2 weeks post-BMT. B cells with anti-Gal Ig receptors were present in the spleens of 2-week but not 12-week chimeras. In vitro studies and adoptive transfer studies using B6 GalT(-/-)B cell-deficient recipients showed that B cell hyporesponsiveness to Gal at 2 weeks, but not 12 weeks, depended on persistent Gal antigen. Thus, pre-existing B-1 cells are anergic when there is continuous exposure to Gal, whereas long-term unresponsiveness does not require persistent antigen, implicating clonal deletion and/or receptor editing. These results have implications for the potential use of mixed hematopioetic chimerism as an approach to performing organ transplantation in recipients with pre-existing anti-donor IgM antibodies.
通过非清髓性骨髓移植(BMT)诱导产生的混合造血嵌合体,会导致α1,3-半乳糖基转移酶缺陷(GalT(-/-))小鼠中产生抗Galα1,3Galβ1,4GlcNAc(Gal)天然抗体(NAb)的细胞无反应性。我们分析了Gal(+/+) BMT诱导抗Gal产生的B细胞无反应性的机制。C57BL/6(B6)GalT(-/-)小鼠接受3Gy全身照射,并接受来自B6-CD45同基因小鼠的BMT。BMT导致BMT后2周血清抗Gal IgM水平和脾脏中抗Gal产生细胞数量显著降低。具有抗Gal Ig受体的B细胞存在于2周龄嵌合体的脾脏中,但不存在于12周龄嵌合体的脾脏中。使用B6 GalT(-/-) B细胞缺陷受体的体外研究和过继转移研究表明,B细胞在2周龄时对Gal反应低下,但在12周龄时并非如此,这取决于持续存在的Gal抗原。因此,当持续接触Gal时,预先存在的B-1细胞会无反应,而长期无反应性并不需要持续存在的抗原,这意味着克隆缺失和/或受体编辑。这些结果对于将混合造血嵌合体作为一种方法用于在预先存在抗供体IgM抗体的受体中进行器官移植的潜在应用具有启示意义。